Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) CFO Paul J. Mellett sold 4,500 shares of Enanta Pharmaceuticals stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $49.45, for a total transaction of $222,525.00. Following the completion of the transaction, the chief financial officer now directly owns 121,897 shares of the company’s stock, valued at approximately $6,027,806.65. On Wednesday shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) closed at $36.03.
On 30 January, Pfizer Inc. (NYSE:PFE) announced its decision to terminate the $70 million collaboration deal with Repligen Corporation (NASDAQ:RGEN) for developing treatments for spinal muscular atrophy (SMA), returning some early stage treatments to Repligen. Pfizer Inc. (NYSE:PFE) has 0.02% insider ownership while its institutional ownership stands at 72.00%. In last trading activity company’s stock closed at $32.07.
On 30 January, MoSys, Inc. (NASDAQ:MOSY) reported financial results for the fourth quarter and fiscal year ended December 31, 2014. Total net revenue for the fourth quarter of 2014 was $1.1 million, compared with $1.1 million reported in the third quarter of 2014 and $1.0 million in the fourth quarter of 2013. MoSys, Inc. (NASDAQ:MOSY) has 3.00% insider ownership while its institutional ownership stands at 42.10%. In last trading activity company’s stock closed at $2.17.
On 27 January, Capital City Bank Group Inc. (NASDAQ:CCBG) reported net income of $1.9 million, or $0.11 per diluted share for the fourth quarter of 2014, compared to net income of $2.1 million, or $0.12 per diluted share for the third quarter of 2014, and net income of $2.8 million, or $0.16 per diluted share, for the fourth quarter of 2013. For the full year 2014, the Company reported net income of $9.3 million, or $0.53 per diluted share, compared to net income of $6.0 million, or $0.35 per diluted share in 2013. On last trading day Capital City Bank Group Inc. (NASDAQ:CCBG) moved down -0.20% to close at $15.32. Its volatility for the week is 2.62% while volatility for the month is 3.97%. CCBG’s sales growth for past 5 years was -8.60% and its EPS growth for past 5 years was 36.00%. Capital City Bank Group Inc. (NASDAQ:CCBG) monthly performance is -2.54%.